Innovative Program Supports Cancer Survivors in Reintegrating into the Workforce

A new online support program from McGill University shows promising results in helping cancer survivors confidently return to work, addressing an important aspect of recovery often overlooked in cancer care. The initiative aims to improve quality of life and reduce economic impact for survivors and employers.
A pioneering pilot initiative led by researchers from McGill University is demonstrating promising results in aiding cancer survivors to confidently return to their jobs, addressing a significant but often overlooked aspect of recovery. The program, known as iCanWork, is an online support system developed by Associate Professor Christine Maheu from McGill's Ingram School of Nursing, in partnership with BC Cancer.
Maheu emphasizes that employment is not traditionally considered a key health indicator within cancer care frameworks, despite it being a primary concern for many patients from the point of diagnosis. Maintaining employment is associated with higher quality of life for survivors. That said, lingering side effects of cancer treatments such as fatigue, cognitive issues like 'chemo brain', and anxiety can hinder focus, organization, and stress management, making the return to work seem daunting.
Early results from a randomized trial involving 24 cancer survivors highlight the program's potential. The study, published in the journal Current Oncology, involved a 10-step virtual program where survivors worked with counselors and therapists to overcome re-entry barriers. The results were encouraging: half of the participants resumed full-time employment within three months, compared to just over one-third of those in the control group. Participants also reported improved effectiveness at work, increased social connection, and reduced pain interference in daily activities. Some participants expressed that without the program, they might have quit their jobs or even considered early retirement, which they now have deferred.
This initiative aims to fill a critical gap in Canadian cancer care, as only 4% of employers have policies tailored to cancer-related return-to-work processes—policies that are more common in some European nations. The economic implications are significant; cancer survivors often face over $2,500 in monthly lost wages and out-of-pocket expenses, while employers bear costs of up to $24,000 to replace an employee on medical leave. Proper support mechanisms like iCanWork could benefit both employees and employers, improving recovery and reducing financial strain.
The research team is now preparing a larger-scale trial and looking to expand the program across Canada. Though the structured program is still in development, survivors can access resources through the Cancer and Work website, launched in 2016 and awarded the 2020 CIHR Inclusive Research Excellence Prize for its accessible design.
For more details, the study is available via DOI: 10.3390/curroncol32050266. This effort aligns with broader mental health and wellness strategies, recognizing the importance of holistic recovery for cancer survivors.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Research Links Chronic Cannabis Use to Increased Cardiovascular Risks
Chronic cannabis use, whether smoked or ingested, is associated with impaired blood vessel function and increased cardiovascular risks, according to recent research. This highlights the importance of understanding cannabis's impact on heart health.
UK Investigates Genetic Factors Linking Obesity Medications and Pancreatitis Risk
The UK is investigating genetic factors that may increase the risk of pancreatitis in patients using obesity drugs like Wegovy and Zepbound. Authorities are calling for reports from affected individuals to better understand this potential genetic link and ensure patient safety.
Rethinking AD: Should It Stand for Alzheimer’s Disease or Auguste Deter?
Exploring whether 'AD' should honor Auguste Deter, the first patient described with Alzheimer’s Disease, or the discoverer, Dr. Alzheimer. Discover the human story behind this devastating neurological condition.